Form 4: Chime Director Sells Shares Under 10b5-1 Plan

Chime Financial Director James Feuille sold 7,229 shares of Class A Common Stock for $24.82 per share under a pre-arranged trading plan.

Summary

• James Feuille, a Director of Chime Financial, Inc. (CHYM), reported a sale of Class A Common Stock.
• On December 16, 2025, Feuille disposed of 7,229 shares at a weighted average price of $24.82 per share.
• The shares were sold in multiple transactions with prices ranging from $24.79 to $24.90.
• This transaction was conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following the sale, Feuille directly beneficially owns 7,628 shares of Class A Common Stock.
• Feuille also indirectly beneficially owns a significant number of shares through various entities where he is a managing member or trustee, including:
• Crosslink Crossover Fund VI, L.P.: 7,037,707 shares
• Crosslink Ventures VII, L.P.: 10,249,701 shares
• Crosslink Ventures VII-B, L.P.: 4,392,033 shares
• Crosslink Bayview VII, LLC: 1,085,859 shares
• Crosslink Ventures VII Holdings, LLC: 59,780 shares
• An irrevocable trust: 34,715 shares
• A revocable trust: 12,875 shares

Sentiment

Score: 5

Explanation: The sentiment is neutral. A director's sale of shares, especially when conducted under a pre-arranged 10b5-1 plan, is generally considered a routine personal financial management event rather than a reflection of the company's immediate prospects. It does not inherently signal strong positive or negative news for the company.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale not based on immediate, non-public information, which enhances transparency.

Negatives

• A director's sale of shares, even if pre-planned, reduces their direct ownership stake in the company, which can sometimes be perceived negatively by investors.

Risks

• Potential negative investor perception regarding insider selling, despite the transaction being pre-planned under a Rule 10b5-1 plan.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transaction reports like Form 4 are routine disclosures in the financial industry. Sales made under Rule 10b5-1 plans are common for executives and directors to manage personal finances and diversify holdings while adhering to insider trading regulations, providing a structured approach to stock sales.

Related Party Transactions

• James Feuille disclaims beneficial ownership of shares held indirectly through Crosslink Crossover Fund VI, L.P., Crosslink Ventures VII, L.P., Crosslink Ventures VII-B, L.P., Crosslink Bayview VII, LLC, and Crosslink Ventures VII Holdings, LLC, except to the extent of his pecuniary interest therein, as he is a managing member of the general partners or managers of these entities.
• Feuille also disclaims beneficial ownership of shares held by an irrevocable trust and a revocable trust, except to the extent of his proportionate pecuniary interest therein, as he is a trustee for these trusts.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but the pre-planned nature of the sale under Rule 10b5-1 mitigates concerns about its implications for the company's future performance.

Key Dates

Recommendation

The filing reports a routine insider sale by a director under a pre-arranged 10b5-1 plan. This type of transaction is common for personal financial management and does not typically indicate a change in the company's fundamental outlook or warrant a shift in investment recommendation. Investors should continue to evaluate the company based on its broader financial performance and strategic initiatives.

Keywords

Chime Financial, CHYM, Form 4, insider trading, stock sale, director, James Feuille, 10b5-1 plan, beneficial ownership